Recent News
March 29, 2024
Neuropeutics is exhibiting at DiscoveryX hosted by Ontario Center of Innovation. Read more |
March 7, 2024
Neuropeutics wins 2nd Place Award and People's Choice Award at Desjardins Pitch Competition. Read more |
February 20, 2024
Neuropeutics selected as a finalist for Early-Stage Desjardins Pitch Competition |
October 25, 2023
Neuropeutics’ founders awarded the Connaught Innovation Award |
September 12, 2023
Neuropeutics wins People Choice Award at Lab2Market Launch National Health Cohort Virtual Pitch |
September 6, 2023
Neuropeutics accepted into the CDL program, Neuro Stream in Toronto |
July 7, 2023
Neuropeutics participates in Summer by Design program. |
July 1, 2023
Dr. Marc Shenouda awarded AFTD Holloway Postdoctoral Fellowship to continue developing therapeutics for ALS/FTD. |
June 6, 2023
Neuropeutics joins Lab2Market Launch summer accelerator |
May 16, 2023
Neuropeutics’ founders present “Small Molecule Targeting of {IP Protein} prevents and reverses TDP-43 aggregation in vitro and in vivo” at 2nd ALS Drug Development Summit. |
May 8, 2023
Neuropeutics wins 2nd place in KITE ICAIR Pitch Concept |